S8367 (2023-24 session)
NY State bill
Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.
- Title
- Relates to capping cost sharing for antiviral COVID-19 therapeutics
- Type
- New York State Senate bill
- Session
- 2023-24 session
- Status
- In Assembly Committee
- Latest action date
- 2024-06-05
- In committee
- Insurance
- Introduced
- 2024-01-23
- Active version
- S8367B
- Same as
- A9662
- Law section
- Insurance Law
Sponsors
Heard in committee
- Insurance NY State Assembly committee
- Insurance NY State Senate committee
- Rules NY State Senate committee
Same as
- A9662 (2023-24 session) NY State bill
Committee meetings
Committee meetings that took this bill up, from the Senate's published agendas. The Assembly does not publish its committee agendas in machine-readable form, so an Assembly committee's consideration of a bill is not on this list.
- Rules, 2024-05-28 Third reading